Skip to main content

American Cancer Society Institutional Research Grant (ACS-IRG)

The Institutional Research Grant (IRG) is awarded by the American Cancer Society and distributed by Huntsman Cancer Institute's Office of Cancer Research Training and Education Coordination. It offers opportunities to faculty who have yet to secure significant funding. Each award cycle, three selected applicants will receive $40,000.

Eligibility

  • Early career faculty members who are within the first six years of their appointment and who have not successfully earned a national funded grant. 
  • The project must be cancer focused, but can be from a broad set of disciplines including basic science, translational research, and population science.
  • Huntsman Cancer Institute membership or affiliation is not a requirement.

Application Review

  • The local IRG review committee will evaluate for cancer relevance, investigator potential, feasibility of the experimental plan, and likelihood of leveraging the IRG award for extramural funding.  

Timeline

  • Call for applications is in the early fall.
  • The application deadline will be 6-8 weeks after the call for application.
  • Funding will be provided at the beginning of the year.

For more information, contact Kelly Chanthapanya, CRTEC program coordinator, at Kelly.Chanthapanya@hci.utah.edu.
 

Principal Investigator

Donald E. Ayer, PhD

Principal Investigator

An investigator at Huntsman Cancer Institute (HCI) and a professor in the Department of Oncological Sciences at the University of Utah (U of U). He is a member of the Nuclear Control of Cell Growth and Differentiation Program.

2026 IRG Awardees

Xi Qiao, Ph.D.

Xi Qiao, Ph.D.

Research Assistant Professor

Department of Internal Medicine

Statistical Innovation for Deciphering the Microbiome-Mediated Pathways in Hematopoietic Stem Cell Transplantation
 

Jaroslav (Jerry) Zak, DPhil, Ph.D.

Jaroslav (Jerry) Zak, DPhil, Ph.D.

Assistant Professor of Radiation Oncology and Adjunct Assistant

Department of Radiation Oncology

Developing pretreatment assay to predict JAK/PD1 blockade clinical response and evaluating efficacy of new JAKinibs

Eric Smith, M.D., Ph.D

Eric Smith, M.D., Ph.D

Research Instructor

Department of Pathology

Diagnosing and demystifying tyfonas alterations in acral melanoma